Intuitive Surgical (NASDAQ:ISRG) had its price objective boosted by equities researchers at Wells Fargo & Co from $575.00 to $635.00 in a research note issued to investors on Wednesday, September 12th, The Fly reports. The firm currently has an “outperform” rating on the medical equipment provider’s stock. Wells Fargo & Co’s price target would suggest a potential upside of 15.73% from the stock’s previous close.
ISRG has been the topic of several other reports. Goldman Sachs Group upped their price objective on shares of Intuitive Surgical from $540.00 to $630.00 and gave the stock a “buy” rating in a research note on Friday, July 20th. BidaskClub cut shares of Intuitive Surgical from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, August 22nd. Zacks Investment Research upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating and set a $582.00 target price on the stock in a research report on Tuesday, July 24th. Bank of America upped their target price on shares of Intuitive Surgical from $510.00 to $600.00 and gave the stock a “buy” rating in a research report on Tuesday, July 17th. Finally, Northland Securities restated a “sell” rating and issued a $300.00 price objective on shares of Intuitive Surgical in a report on Friday, July 20th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have assigned a buy rating to the company’s stock. Intuitive Surgical has an average rating of “Buy” and an average price target of $529.34.
Shares of ISRG stock traded down $5.73 on Wednesday, hitting $548.71. The company’s stock had a trading volume of 784,750 shares, compared to its average volume of 776,462. Intuitive Surgical has a fifty-two week low of $350.00 and a fifty-two week high of $581.12. The firm has a market cap of $65.29 billion, a PE ratio of 76.32, a PEG ratio of 4.20 and a beta of 0.89.
Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, July 19th. The medical equipment provider reported $2.76 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.02 by $0.74. Intuitive Surgical had a net margin of 23.20% and a return on equity of 20.56%. The firm had revenue of $909.30 million during the quarter, compared to analyst estimates of $877.43 million. During the same quarter in the previous year, the business earned $5.95 EPS. The business’s revenue was up 19.8% on a year-over-year basis. Sell-side analysts anticipate that Intuitive Surgical will post 9.31 earnings per share for the current fiscal year.
In other news, Director Mark J. Rubash sold 350 shares of the firm’s stock in a transaction dated Friday, August 31st. The shares were sold at an average price of $560.00, for a total transaction of $196,000.00. Following the completion of the sale, the director now owns 4,316 shares in the company, valued at approximately $2,416,960. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Craig H. Barratt sold 2,500 shares of the firm’s stock in a transaction dated Tuesday, July 24th. The stock was sold at an average price of $522.00, for a total transaction of $1,305,000.00. The disclosure for this sale can be found here. In the last quarter, insiders sold 109,463 shares of company stock valued at $57,194,982. Corporate insiders own 2.20% of the company’s stock.
Several hedge funds and other institutional investors have recently bought and sold shares of the company. Optimum Investment Advisors raised its stake in Intuitive Surgical by 189.9% in the 3rd quarter. Optimum Investment Advisors now owns 229 shares of the medical equipment provider’s stock worth $131,000 after purchasing an additional 150 shares in the last quarter. Adviser Investments LLC acquired a new stake in Intuitive Surgical in the 2nd quarter worth about $115,000. Signet Financial Management LLC acquired a new stake in Intuitive Surgical in the 2nd quarter worth about $115,000. Psagot Investment House Ltd. acquired a new stake in Intuitive Surgical in the 2nd quarter worth about $133,000. Finally, Kaizen Advisory LLC raised its stake in Intuitive Surgical by 156.0% in the 2nd quarter. Kaizen Advisory LLC now owns 279 shares of the medical equipment provider’s stock worth $133,000 after purchasing an additional 170 shares in the last quarter. Institutional investors own 84.80% of the company’s stock.
About Intuitive Surgical
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. The company's da Vinci surgical System translates a surgeon's natural hand movements, which are performed on instrument controls at a console into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Recommended Story: Do You Need a Fiduciary?
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.